参考文献Refeences:
1.Canosine:avesatileantioxidantandantiglycatingagent.
ReddyVP,etal.
SciAgingKnowledgeEnvion.2005May4;2005(18):pe12.
2.Biologicallyactivedietaypeptides.
ZalogaGP,SiddiquiRA.
MiniRevMedChem.2004Oct;4(8):815-21.
3.Iscanosineanatuallyoccuingsuppessoofoxidativedamageinolfactoyneuones?
HipkissAR.
RejuvenationRes.2004Winte;7(4):253-5.
4.Reactionofcanosinewithagedpoteins:anothepotectivepocess?
HipkissAR,BownsonC,BetaniMF,RuizE,FeoA.
AnnNYAcadSci.2002Ap;959:285-94.
5.Double-blind,placebo-contolledstudyofL-canosinesupplementationinchildenwithautisticspectumdisodes.
ChezMG,BuchananCP,AimonovitchMC,BeckeM,SchaefeK,BlackC,KomenJ.
JChildNeuol2002Nov;17(11):833-7
6.Canosine:physiologicalpopetiesandtheapeuticpotential.
GaiballaSE,SinclaiAJ.
AgeAgeing.2000May;29(3):207-10.
7.Useofcanosineasanatualanti-senescencedugfohumanbeings.
WangAM,MaC,XieZH,ShenF.
JBiochemisty(Mosc).2000Jul;65(7):869-71.
8.Cadiovasculaeffectsofcanosine.
Biochemisty(Mosc).2000Jul;65(7):856-61.
RobetsPR,ZalogaGP.
9.Apossiblenewolefotheanti-ageingpeptidecanosine.
HipkissAR,BownsonC.
CellMolLifeSci.2000May;57(5):747-53.
10.Anti-ischemicactivityofcanosine.
StvolinskySL,DobotaD.
Biochemisty(Mosc).2000Jul;65(7):849-55.
11.Canosine:itspopeties,functionsandpotentialtheapeuticapplications.
QuinnPJ,BoldyevAA,FomazuykVE.
MolAspectsMed.1992;13(5):379-444.
